Stock 688212 SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Shanghai AoHua Photoelectricity Endoscope Co., Ltd.

Equities

688212

CNE100004ZJ5

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-17 pm EDT 		5-day change 1st Jan Change
52.79 CNY -0.19% Intraday chart for Shanghai AoHua Photoelectricity Endoscope Co., Ltd. -3.93% -14.90%
Feb. 26 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Shanghai Aohua Photoelectricity Endoscope Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company's profit outlook over the next few years is a strong asset.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • With an expected P/E ratio at 69.35 and 39.59 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD. Stock Shanghai AoHua Photoelectricity Endoscope Co., Ltd.
-14.90% 978M -
QUIDELORTHO CORPORATION Stock QuidelOrtho Corporation
-48.09% 2.56B
C+
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD. Stock Inner Mongolia Furui Medical Science Co., Ltd.
+4.82% 1.66B - -
SHANGHAI MICROPORT EP MEDTECH CO., LTD. Stock Shanghai MicroPort EP MedTech Co., Ltd.
-12.79% 1.45B -
BIOTAGE AB Stock Biotage AB
+22.29% 1.2B
B+
CONTEC MEDICAL SYSTEMS CO.,LTD Stock Contec Medical Systems Co.,Ltd
-23.61% 875M -
C-
REVENIO GROUP OYJ Stock Revenio Group Oyj
-9.43% 698M -
VAREX IMAGING CORPORATION Stock Varex Imaging Corporation
-17.46% 687M
B+
CELLAVISION AB Stock CellaVision AB
+3.77% 480M
C+
PHC CO.,LTD. Stock PHC Co.,Ltd.
-.--% 301M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 688212 Stock
  4. Ratings Shanghai AoHua Photoelectricity Endoscope Co., Ltd.